Teva

EPOPROSTENOL SODIUM

  1. Home
  2.  / 
  3. J Code
  4.  / EPOPROSTENOL SODIUM – J1325

Manufacturer:

Teva

Name:

EPOPROSTENOL SODIUM

HCPCS Code Descriptor:

Injection, epoprostenol, 0.5 mg

Category:

J Code

HCPCS:

J1325

NDC(s):

66215-0402-01, 66215-0403-01, 62756-0059-40, 62756-0060-40, 00703-1995-01, 00703-1985-01, 00173-0517-00, 00173-0519-00

Primary Type:

Cardiology

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

EPOPROSTENOL SODIUM is a Cardiology drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J1325 is aligned to the drug EPOPROSTENOL SODIUM.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/98

HCPCS Effective Date:

1/1/98

HCPCS Short Description:

Epoprostenol injection

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found